HCV Peptide (257-266)

Catalog No. :
ACOGRW481
CAS No. :
199533-16-9
Molecular Formula :
C54H96N18O14
Molecular Weight :
1221.47

IUPAC Name:(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,30R)-17-((1H-imidazol-5-yl)methyl)-29-amino-26-((S)-sec-butyl)-11-(carboxymethyl)-20,23-bis(3-((diaminomethylene)amino)propyl)-30-hydroxy-5,8-diisobutyl-2,14-diisopropyl-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24,27-nonaazahentriacontanoic acid

HCV Peptide (257-266) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameHCV Peptide (257-266)
IUPAC Name(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,30R)-17-((1H-imidazol-5-yl)methyl)-29-amino-26-((S)-sec-butyl)-11-(carboxymethyl)-20,23-bis(3-((diaminomethylene)amino)propyl)-30-hydroxy-5,8-diisobutyl-2,14-diisopropyl-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24,27-nonaazahentriacontanoic acid
Molecular FormulaC54H96N18O14
Molecular Weight1221.47
SMILES[C@@H](CC1=CN=CN1)(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]([C@@H](C)O)N)=O)[C@H](CC)C)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](C(C)C)C(O)=O)=O)CC(C)C)=O)CC(C)C)=O)CC(O)=O)=O)[C@H](C)C)=O
InChI KeyJKJOCRQVPYUCPR-AJNZMAQTSA-N
SynonymL-Valine, L-threonyl-L-isoleucyl-L-arginyl-L-arginyl-L-histidyl-L-valyl-L-α-aspartyl-L-leucyl-L-leucyl- (9CI)
CAS No.199533-16-9

Synthetic Route by SureRoute

1. ACOGRW481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOGRW481 route product structure diagram
    ACOGRW481199533-16-9
Inquiry

2. ACOGRW481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOGRW481 route product structure diagram
    ACOGRW481199533-16-9
Inquiry

Comments (0)